Skip to content

Depression: all studies

Page 772 of 1,036: studies 7,711 to 7,720 of 10,358, newest first. Back to the depression overview

Research

Stay mindfully active during the coronavirus pandemic: a feasibility study of mHealth-delivered mindfulness yoga program for people with Parkinson's disease.

BMC Complementary Medicine and Therapies February 7, 2022 Jojo Yan Yan Kwok, Jung Jae Lee, Edmond Pui Hang Choi et al.

Importance: Patients with long-term neurological conditions, such as Parkinson's disease (PD), are particularly vulnerable to the public health measures taken to combat the COVID-19 pandemic. The inaccessibility of center-based rehabilitation further aggravated their motor dysfunctions as well as mental distress, leading to exacerbation of motor and non-motor symptoms, high healthcare...

DOI: 10.1186/s12906-022-03519-y (opens in new tab) Full text (opens in new tab) Mindfulness Humans Parkinson disease Gait disorders, neurologic +17

Hallucinogen chemistry guides antidepressant drug discovery

C&EN Global Enterprise February 7, 2022 Bethany Halford

Scientists have long sought the secrets of the 5-HT 2A serotonin receptor—a central nervous system receptor that binds hallucinogenic compounds, including LSD and psilocybin. Many hope to discover why these molecules cause hallucinations when they bind to 5-HT 2A while other compounds that bind to the receptor, including serotonin, do not. LSD and psilocybin have been shown to treat mood...

DOI: 10.1021/cen-10005-leadcon (opens in new tab) Hallucinogen Antidepressant Drug discovery Pharmacology

Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD)

ACS Omega February 7, 2022 Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer et al. 5 citations

Psilocybin, a serotonergic agonist, was granted a "breakthrough therapy" status by the Food and Drug Administration for clinical trials involving major depressive disorder and treatment-resistant depression. The direct phosphorylation of psilocin to psilocybin that uses a fast crystallization associated with a kinetically controlled process resulted in a smaller particle size distribution....

DOI: 10.1021/acsomega.1c06708 (opens in new tab) Psilocybin Nucleation Metastability Recrystallization geology +7

Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?

Journal of Xenobiotics February 7, 2022 Maurizio Coppola, Francesco Bevione, Raffaella Mondola 29 citations

Psychedelics extracted from plants have been used in religious, spiritual, and mystic practices for millennia. In 1957, Dr. Hofmann identified and synthesized the prodrug psilocybin, a substance present in more than 200 species of psychedelic mushrooms. Although there were limitations related to the scientific design of many studies, clinical observations performed during the 1950s and 1960s...

The relationships between self-transcendence and depressive symptoms, self-esteem, and locus of control in individuals diagnosed with substance addiction.

Perspectives In Psychiatric Care February 5, 2022 Seda Er, Sevim Buzlu

AIMS This study examined the relationships between self-transcendence and depressive symptoms, self-esteem, and locus of control in persons with substance abuse disorder (SUDs). METHODS This descriptive-relational study examined 115 participants who had been diagnosed with SUD. RESULTS High self-transcendence scores were positively associated with lower levels of depressive symptoms, higher...

Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review

Cureus February 5, 2022 Shawn Ziff, Benjamin Stern, Gregory D. Lewis et al. 32 citations

Psilocybin-containing mushrooms have been consumed by various cultures in many different parts of the world for thousands of years. Psilocybin, a classic psychedelic, contains unique psychoactive properties and has been incorporated into religious ceremonies and investigated for its medicinal value. In the mid-20th century, psilocybin, along with most other classic psychedelics (5HT-2A...

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial

British medical journal February 2, 2022 M. Abbar, C. Demattei, Wissam El-Hage et al. 172 citations

Abstract Objective To confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks, overall and according to diagnostic group. Design Prospective, double blind, superiority, randomised placebo controlled trial. Setting Seven French teaching hospitals between 13 April 2015 and 12 March 2019. Eligibility criteria for participants Aged 18 or older with current...

An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration February 2022 Francesco Pagnini, Deborah Phillips, Anne Haulman et al.

Objectives: Mindfulness-based interventions seem to be effective in promoting QOL of ALS patients and caregivers, but most require substantial time. In the Langerian approach, mindfulness can be easily promoted with mental tasks and short lectures. This study aims to explore the impact of an ALS-specific online Langerian mindfulness training program on QOL of ALS patients. Methods: We developed...

DOI: 10.1080/21678421.2021.1928707 (opens in new tab) Full text (opens in new tab) Mindfulness Amyotrophic lateral sclerosis Caregivers Psychological intervention +1

Nightmares mediate the association between traumatic event exposure and suicidal ideation in frontline medical workers exposed to COVID-19

Journal of Affective Disorders February 1, 2022 Jianyu Que, Le Shi, Wei Yan et al.

Background Trauma experience increases the risk of suicidal ideation, but little is known about potentially psychological mechanisms underlying this relationship. This study aims to examine the relationship between coronavirus disease 2019 (COVID-19)-related traumatic event (CTE) exposure and suicidal ideation among hospital workers, and identify mediating roles of sleep disturbances in this...

A Pilot Randomized Controlled Trial of Transcendental Meditation as Treatment for Posttraumatic Stress Disorder in Veterans.

Journal of Traumatic Stress February 1, 2022 Mayer Bellehsen, Valentina Stoycheva, Barry H. Cohen et al.

Preliminary studies have demonstrated the efficacy of Transcendental Meditation (TM) for treating posttraumatic stress disorder (PTSD). The present study extended previous research with a pilot trial of TM as a treatment for PTSD via a single-blinded, randomized controlled design. veterans with PTSD (N = 40) were assigned to a TM intervention or treatment-as-usual (TAU) control group....